David Toung
Stock Analyst at Argus Research
(3.36)
# 1,009
Out of 5,127 analysts
129
Total ratings
65%
Success rate
10.03%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $64.58 | +5.30% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $606.50 | +0.58% | 8 | Oct 29, 2025 | |
| HOLX Hologic | Maintains: Buy | $80 → $90 | $74.87 | +20.21% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $98.69 | +16.53% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $277.57 | +1.59% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $374.77 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $38.91 | +33.64% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $346.85 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $13.86 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $224.13 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $202.49 | -38.27% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $215.62 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $330.11 | +3.00% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $814.63 | -17.75% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $94.08 | +59.44% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,085.19 | -22.59% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $88.16 | +24.77% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $254.67 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.29 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $367.21 | -15.58% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $479.02 | -35.28% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $585.08 | -45.31% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $126.18 | +6.99% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $120.66 | -37.84% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $55.90 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $110.99 | -0.89% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.63 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $94.01 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $141.46 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $205.75 | -24.67% | 4 | Mar 27, 2020 |
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $64.58
Upside: +5.30%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $606.50
Upside: +0.58%
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $74.87
Upside: +20.21%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $98.69
Upside: +16.53%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $277.57
Upside: +1.59%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $374.77
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $38.91
Upside: +33.64%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $346.85
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $13.86
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $224.13
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $202.49
Upside: -38.27%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $215.62
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $330.11
Upside: +3.00%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $814.63
Upside: -17.75%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $94.08
Upside: +59.44%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,085.19
Upside: -22.59%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $88.16
Upside: +24.77%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $254.67
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.29
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $367.21
Upside: -15.58%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $479.02
Upside: -35.28%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $585.08
Upside: -45.31%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $126.18
Upside: +6.99%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $120.66
Upside: -37.84%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $55.90
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $110.99
Upside: -0.89%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.63
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $94.01
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $141.46
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $205.75
Upside: -24.67%